ArticleFrontiers in endocrinology2025

Correction: A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists - a comprehensive review.

David Aristizábal-Colorado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.